Previously, common polymorphic variants from the promoter regions of GRIA1, GRIA3, GRIN1, or GRIN2A were associated with susceptibility to addiction, migraine, or schizophrenia [32,63,64,65]. Here, GRIN2A is linked to migraine disorder.